---
title: "Konruns: There is no significant information that should be disclosed but has not been disclosed"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255446569.md"
description: "On the evening of September 1st, Konruns announced a stock trading anomaly, stating that after self-examination and written inquiries with the controlling shareholder and actual controller, there are no significant undisclosed information that should be disclosed, apart from the matters already disclosed by the company"
datetime: "2025-09-01T10:18:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255446569.md)
  - [en](https://longbridge.com/en/news/255446569.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255446569.md)
---

# Konruns: There is no significant information that should be disclosed but has not been disclosed

On the evening of September 1st, Konruns Pharmaceuticals issued a stock trading anomaly announcement stating that, after self-examination and written inquiries with the controlling shareholder and actual controller, there are no significant undisclosed information that should be disclosed, apart from the matters already disclosed by the company

### Related Stocks

- [603590.CN](https://longbridge.com/en/quote/603590.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants | ANVS Stock News](https://longbridge.com/en/news/286960443.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)